McKinley Capital Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

McKinley Capital Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-31,041	Closed	-$1.42M	–	358
2017 Q4	$1.42M	Buy	31,041 +25,133	+425%	+$1.25M	0.07%	190
2017 Q3	$265K	Buy	+5,908	New	+$201K	0.01%	294
2016 Q1	–	Sell	-2,646	Closed	-$116K	–	403
2015 Q4	$116K	Buy	2,646 +11	+0.4%	+$546	0.01%	320
2015 Q3	$107K	Buy	+2,635	New	+$116K	0.01%	319

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

McKinley Capital Management's JUNO Position: Q1 2018 in Review

McKinley Capital Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 31,041 shares — an estimated $1.42M sold.

McKinley Capital Management first reported a position in JUNO in Q3 2015 and held it in 4 quarters. The position peaked at $1.42M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

McKinley Capital Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
McKinley Capital Management sold 31,041 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.42M.
McKinley Capital Management first reported a position in Juno Therapeutics, Inc. in Q3 2015 and held it in 4 quarters.
McKinley Capital Management's Juno Therapeutics, Inc. position peaked at $1.42M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on McKinley Capital Management's 13F filing for Q1 2018, filed 4 May 2018.